Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Francis E Jr Odonnell. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Francis E Jr Odonnell har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:INTI / Inhibitor Therapeutics, Inc. | See Remarks, Director, 10% Owner | 85 627 069 |
| US:BDSI / Biodelivery Sciences International | Director | 0 |
| US:ABPI / | Director | 1 960 992 |
| FORMER DIRECTOR/EXEC. CHAIRMAN, Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Francis E Jr Odonnell. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp INTI / Inhibitor Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i INTI / Inhibitor Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i INTI / Inhibitor Therapeutics, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-06-15 | HPPI | ODONNELL FRANCIS E JR | 2 560 000 | 2 560 000 | 0 | 0.1531 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Francis E Jr Odonnell som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-22 | 3 | INTI |
Inhibitor Therapeutics, Inc.
Common Stock |
85 627 069 | ||||||||
| 2020-05-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −22 500 | 0 | −100,00 | ||||
| 2020-05-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 22 500 | 628 038 | 3,72 | ||||
| 2020-05-08 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −11 250 | 605 538 | −1,82 | 4,53 | −50 962 | 2 743 087 |
| 2020-05-05 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −16 000 | 616 788 | −2,53 | 4,45 | −71 200 | 2 744 707 |
| 2020-04-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −20 000 | 632 788 | −3,06 | 4,22 | −84 400 | 2 670 365 |
| 2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −30 500 | 656 072 | −4,44 | 3,63 | −110 715 | 2 381 541 |
| 2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −15 000 | 0 | −100,00 | ||||
| 2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −62 500 | 0 | −100,00 | ||||
| 2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −38 750 | 686 572 | −5,34 | 3,60 | −139 500 | 2 471 659 |
| 2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 18 284 | 725 322 | 2,59 | ||||
| 2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 15 000 | 700 470 | 2,19 | ||||
| 2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 15 000 | 688 754 | 2,23 | ||||
| 2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 62 500 | 673 754 | 10,22 | ||||
| 2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 62 500 | 611 254 | 11,39 | ||||
| 2020-02-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 548 754 | −1,44 | 5,31 | −42 480 | 2 913 884 |
| 2020-01-03 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 556 754 | −1,42 | 6,10 | −48 800 | 3 396 199 |
| 2019-12-31 |
|
4/A | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
| 2019-12-31 |
|
4/A | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −10 000 | 564 754 | −1,74 | 7,00 | −70 000 | 3 953 278 | |
| 2019-12-31 |
|
4/A | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 10 000 | 574 754 | 1,77 | 1,96 | 19 600 | 1 126 518 | |
| 2019-12-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −10 000 | 554 754 | −1,77 | 7,00 | −70 000 | 3 883 278 |
| 2019-12-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 564 754 | −1,40 | 6,86 | −54 880 | 3 874 212 |
| 2019-11-05 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 572 754 | −1,38 | 5,83 | −46 640 | 3 339 156 |
| 2019-10-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy) |
M - Exercise | −32 500 | 0 | −100,00 | ||||
| 2019-10-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −32 500 | 580 754 | −5,30 | 6,00 | −195 000 | 3 484 524 |
| 2019-10-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | X | 32 500 | 613 254 | 5,60 | 3,47 | 112 775 | 2 127 991 |
| 2019-10-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy) |
M - Exercise | X | −32 500 | 0 | −100,00 | |||
| 2019-10-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −32 500 | 580 754 | −5,30 | 5,00 | −162 500 | 2 903 770 |
| 2019-10-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | X | 32 500 | 613 254 | 5,60 | 2,26 | 73 450 | 1 385 954 |
| 2019-10-03 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 580 754 | −1,36 | 4,34 | −34 720 | 2 520 472 |
| 2019-09-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 588 754 | −1,34 | 4,29 | −34 320 | 2 525 755 |
| 2019-08-02 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 596 754 | −1,32 | 3,82 | −30 560 | 2 279 600 |
| 2019-07-03 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 604 754 | −1,31 | 4,68 | −37 440 | 2 830 249 |
| 2019-06-05 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 612 754 | −1,29 | 4,32 | −34 560 | 2 647 097 |
| 2019-05-10 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −22 500 | 22 500 | −50,00 | ||||
| 2019-05-10 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 22 500 | 620 754 | 3,76 | ||||
| 2019-05-03 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 598 254 | −1,32 | 4,77 | −38 160 | 2 853 672 |
| 2019-04-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (Right to Buy) |
A - Award | 22 500 | 22 500 | |||||
| 2019-04-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 45 000 | 45 000 | |||||
| 2019-04-03 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 606 254 | −1,30 | 5,19 | −41 520 | 3 146 458 |
| 2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −71 690 | 614 254 | −10,45 | 5,21 | −373 505 | 3 200 263 |
| 2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −9 757 | 0 | −100,00 | ||||
| 2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −15 000 | 0 | −100,00 | ||||
| 2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −15 000 | 30 000 | −33,33 | ||||
| 2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −62 500 | 0 | −100,00 | ||||
| 2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −62 500 | 62 500 | −50,00 | ||||
| 2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 9 757 | 685 944 | 1,44 | ||||
| 2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 15 000 | 676 187 | 2,27 | ||||
| 2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 15 000 | 661 187 | 2,32 | ||||
| 2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 62 500 | 646 187 | 10,71 | ||||
| 2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 62 500 | 583 687 | 11,99 | ||||
| 2019-03-01 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −46 000 | 0 | −100,00 | ||||
| 2019-03-01 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −23 000 | 521 187 | −4,23 | 5,07 | −116 610 | 2 642 418 |
| 2019-03-01 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 46 000 | 544 187 | 9,23 | ||||
| 2019-02-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 498 187 | −1,58 | 4,60 | −36 800 | 2 291 660 |
| 2019-01-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 506 187 | −1,56 | 3,64 | −29 120 | 1 842 521 |
| 2018-12-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 514 187 | −1,53 | 3,72 | −29 760 | 1 912 776 |
| 2018-11-02 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 522 187 | −1,51 | 3,84 | −30 720 | 2 005 198 |
| 2018-10-03 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 530 187 | −1,49 | 2,75 | −22 000 | 1 458 014 |
| 2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −53 438 | 0 | −100,00 | ||||
| 2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −62 500 | 125 000 | −33,33 | ||||
| 2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −46 000 | 46 000 | −50,00 | ||||
| 2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −6 806 | 0 | −100,00 | ||||
| 2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −84 372 | 538 187 | −13,55 | 2,84 | −239 616 | 1 528 451 |
| 2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 53 438 | 622 559 | 9,39 | ||||
| 2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 62 500 | 569 121 | 12,34 | ||||
| 2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 46 000 | 506 621 | 9,99 | ||||
| 2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 6 806 | 460 621 | 1,50 | ||||
| 2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −133 333 | 0 | −100,00 | ||||
| 2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −66 667 | 453 815 | −12,81 | 2,83 | −188 668 | 1 284 296 |
| 2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 133 333 | 520 482 | 34,44 | ||||
| 2018-08-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 387 149 | −2,02 | 2,79 | −22 320 | 1 080 146 |
| 2018-06-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option |
M - Exercise | −37 500 | 0 | −100,00 | ||||
| 2018-06-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
F - Taxes | −27 525 | 395 149 | −6,51 | 3,10 | −85 328 | 1 224 962 | |
| 2018-06-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 37 500 | 422 674 | 9,74 | 2,01 | 75 375 | 849 575 | |
| 2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −133 333 | 133 333 | −50,00 | ||||
| 2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −66 666 | 385 174 | −14,75 | 2,14 | −142 665 | 824 272 |
| 2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 133 333 | 451 840 | 41,86 | ||||
| 2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −46 000 | 92 000 | −33,33 | ||||
| 2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −48 418 | 0 | −100,00 | ||||
| 2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −47 210 | 318 507 | −12,91 | 2,13 | −100 557 | 678 420 |
| 2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 46 000 | 365 717 | 14,39 | ||||
| 2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 48 418 | 319 717 | 17,85 | ||||
| 2018-02-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 45 000 | 45 000 | |||||
| 2017-03-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −750 | 271 299 | −0,28 | 1,90 | −1 425 | 515 468 |
| 2017-03-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −2 520 | 0 | −100,00 | ||||
| 2017-03-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 2 520 | 272 049 | 0,93 | ||||
| 2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −6 416 | 269 529 | −2,33 | 1,85 | −11 870 | 498 629 |
| 2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −83 900 | 275 945 | −23,32 | 1,89 | −158 571 | 521 536 |
| 2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −133 334 | 266 666 | −33,33 | ||||
| 2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −48 419 | 48 418 | −50,00 | ||||
| 2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −70 000 | 0 | −100,00 | ||||
| 2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −7 965 | 0 | −100,00 | ||||
| 2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −39 544 | 359 845 | −9,90 | 1,95 | −77 111 | 701 698 |
| 2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 133 334 | 399 389 | 50,12 | ||||
| 2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 48 419 | 266 055 | 22,25 | ||||
| 2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 70 000 | 217 636 | 47,41 | ||||
| 2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 7 965 | 147 636 | 5,70 | ||||
| 2017-02-08 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 187 500 | 187 500 | |||||
| 2016-09-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 1 285 490 | −3,74 | 2,68 | −134 000 | 3 445 113 | |
| 2016-09-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 1 335 490 | −3,61 | 2,45 | −122 500 | 3 271 950 | |
| 2016-06-20 |
|
4/A | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
P - Purchase | 2 560 000 | 16 560 000 | 18,29 | ||||
| 2016-06-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −300 000 | 1 385 490 | −17,80 | ||||
| 2016-06-17 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
S - Sale | −2 560 000 | 11 440 000 | −18,29 | ||||
| 2016-06-08 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
J - Other | −6 000 000 | 14 000 000 | −30,00 | ||||
| 2016-03-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Options |
M - Exercise | −15 000 | 10 000 | −60,00 | ||||
| 2016-03-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 15 000 | 139 671 | 12,03 | 2,05 | 30 750 | 286 326 | |
| 2016-03-02 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 138 000 | 138 000 | |||||
| 2015-12-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −200 000 | 1 685 490 | −10,61 | ||||
| 2015-11-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 1 885 490 | −2,58 | 6,01 | −300 500 | 11 331 795 | |
| 2015-11-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −20 000 | 124 671 | −13,82 | 6,00 | −120 000 | 748 026 | |
| 2015-09-14 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
P - Purchase | 20 000 000 | 20 000 000 | |||||
| 2015-09-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −20 000 | 144 671 | −12,15 | 6,43 | −128 600 | 930 235 |
| 2015-08-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option |
M - Exercise | −25 000 | 0 | −100,00 | ||||
| 2015-08-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
F - Taxes | −11 557 | 164 671 | −6,56 | 6,36 | −73 503 | 1 047 308 | |
| 2015-08-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 25 000 | 176 228 | 16,53 | 2,94 | 73 500 | 518 110 | |
| 2015-06-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −15 000 | 1 935 490 | −0,77 | ||||
| 2015-06-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 1 950 490 | −2,50 | 8,03 | −401 500 | 15 662 435 | |
| 2015-06-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −20 000 | 151 228 | −11,68 | 8,03 | −160 600 | 1 214 361 |
| 2015-06-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −1 597 | 171 228 | −0,92 | 7,97 | −12 728 | 1 364 687 |
| 2015-06-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 4 105 | 172 825 | 2,43 | ||||
| 2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 400 000 | 400 000 | |||||
| 2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −20 000 | 168 720 | −10,60 | 14,56 | −291 200 | 2 456 563 |
| 2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −48 419 | 96 837 | −33,33 | ||||
| 2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 48 419 | 188 720 | 34,51 | ||||
| 2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −70 000 | 70 000 | −50,00 | ||||
| 2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −35 000 | 140 301 | −19,97 | 14,37 | −502 950 | 2 016 125 |
| 2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 70 000 | 175 301 | 66,48 | ||||
| 2015-02-13 |
|
5 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 855 | 105 301 | 0,82 | ||||
| 2015-02-13 |
|
5 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 145 256 | 145 256 | |||||
| 2015-02-13 |
|
5 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
J - Other | −70 000 | 140 000 | −33,33 | ||||
| 2015-02-13 |
|
5 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 210 000 | 210 000 | |||||
| 2014-12-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −20 000 | 105 301 | −15,96 | 11,96 | −239 200 | 1 259 400 | |
| 2014-12-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 2 000 490 | −2,44 | 12,01 | −600 500 | 24 025 885 | |
| 2014-12-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −200 000 | 2 050 490 | −8,89 | ||||
| 2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Series A Convertible Preferred Stock |
J - Other | 18 984 | 64 034 | 42,14 | ||||
| 2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Series A Convertible Preferred Stock |
J - Other | 4 012 | 13 532 | 42,14 | ||||
| 2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Warrant to purchase Common Stock |
J - Other | 2 716 401 | 2 716 401 | |||||
| 2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Warrant to purchase Common Stock |
J - Other | 574 032 | 574 032 | |||||
| 2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
J - Other | 670 510 | 670 510 | |||||
| 2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
J - Other | 141 693 | 141 693 | |||||
| 2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
J - Other | 5 300 000 | 5 970 510 | 790,44 | 0,08 | 397 500 | 447 788 | |
| 2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
J - Other | 1 120 000 | 1 261 693 | 790,44 | 0,08 | 84 000 | 94 627 | |
| 2014-06-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option |
M - Exercise | −35 000 | 0 | −100,00 | ||||
| 2014-06-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
F - Taxes | −6 815 | 2 375 791 | −0,29 | 11,76 | −80 144 | 27 939 302 | |
| 2014-06-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 35 000 | 2 382 606 | 1,49 | 2,29 | 80 150 | 5 456 168 | |
| 2014-06-13 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −125 000 | 2 347 606 | −5,06 | 11,04 | −1 380 000 | 25 917 570 | |
| 2014-03-28 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 2 472 606 | −1,98 | 8,04 | −402 000 | 19 879 752 | |
| 2014-02-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −70 000 | 2 521 751 | −2,70 | 8,92 | −624 400 | 22 494 019 |
| 2014-02-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 70 000 | 2 591 751 | 2,78 | 8,90 | 623 000 | 23 066 584 | |
| 2014-01-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 2 521 751 | −3,81 | 6,01 | −601 000 | 15 155 724 | |
| 2014-01-10 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 2 621 751 | −3,67 | 6,20 | −620 000 | 16 254 856 | |
| 2013-12-26 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 2 721 751 | −1,80 | 5,88 | −294 000 | 16 003 896 | |
| 2013-12-26 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 2 771 751 | −3,48 | 5,91 | −591 000 | 16 381 048 | |
| 2013-12-06 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 2 871 751 | −3,37 | 5,30 | −530 000 | 15 220 280 | |
| 2013-11-15 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 2 971 751 | −3,26 | 4,44 | −444 000 | 13 194 574 | |
| 2013-11-12 |
|
4 | ABPI |
ACCENTIA BIOPHARMACEUTICALS INC
Common Stock |
J - Other | −1 375 000 | 1 960 992 | −41,22 | 0,01 | −13 750 | 19 610 | |
| 2013-09-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 3 071 751 | −1,60 | 5,37 | −268 500 | 16 495 303 | |
| 2013-09-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −45 000 | 3 121 751 | −1,42 | 5,35 | −240 750 | 16 701 368 | |
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −459 550 | 0 | −100,00 | ||||
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −1 950 000 | 0 | −100,00 | ||||
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −125 000 | 0 | −100,00 | ||||
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −1 000 000 | 0 | −100,00 | ||||
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −75 000 | 0 | −100,00 | ||||
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −60 000 | 0 | −100,00 | ||||
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −40 000 | 0 | −100,00 | ||||
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock Warrant (Right to Buy) |
J - Other | −281 250 | 0 | −100,00 | ||||
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock Warrant (Right to Buy) |
J - Other | −414 545 | 0 | −100,00 | ||||
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock |
J - Other | −84 951 | 0 | −100,00 | ||||
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock |
J - Other | −111 610 | 0 | −100,00 | ||||
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock |
J - Other | −2 991 | 0 | −100,00 | ||||
| 2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock |
J - Other | −18 306 | 0 | −100,00 | ||||
| 2013-08-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option |
M - Exercise | −8 891 | 0 | −100,00 | ||||
| 2013-08-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option |
M - Exercise | −26 109 | 0 | −100,00 | ||||
| 2013-08-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
F - Taxes | −30 466 | 3 166 751 | −0,95 | 4,40 | −134 050 | 13 933 704 | |
| 2013-08-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 35 000 | 3 197 217 | 1,11 | 3,83 | 134 050 | 12 245 341 | |
| 2013-08-16 |
|
4 | CBTEQ |
HedgePath Pharmaceuticals, Inc.
Series A Convertible Preferred Stock |
A - Award | 45 050 | 45 050 | |||||
| 2013-08-16 |
|
4 | CBTEQ |
HedgePath Pharmaceuticals, Inc.
Series A Convertible Preferred Stock |
A - Award | 9 520 | 9 520 | |||||
| 2013-06-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −34 258 | 3 162 217 | −1,07 | 4,27 | −146 282 | 13 502 667 | |
| 2013-06-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −14 242 | 3 196 475 | −0,44 | 4,36 | −62 095 | 13 936 631 | |
| 2013-06-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −1 500 | 3 210 717 | −0,05 | 4,45 | −6 675 | 14 287 691 | |
| 2013-06-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −22 689 | 3 212 217 | −0,70 | 4,50 | −102 100 | 14 454 976 | |
| 2013-06-07 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 1 727 | 3 234 906 | 0,05 | 4,30 | 7 426 | 13 910 096 | |
| 2013-04-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 3 075 490 | −3,15 | ||||
| 2012-10-26 |
|
4 | ABPI |
ACCENTIA BIOPHARMACEUTICALS INC
Common Stock |
J - Other | −500 000 | 3 335 992 | −13,03 | ||||
| 2012-06-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 3 175 490 | −3,05 | ||||
| 2012-06-15 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock Warrant (Right to Buy) |
J - Other | −125 000 | 414 545 | −23,17 | ||||
| 2012-04-13 |
|
4 | ABPI |
ACCENTIA BIOPHARMACEUTICALS INC
Common Stock |
J - Other | −100 000 | 3 835 992 | −2,54 | 0,37 | −37 000 | 1 419 317 | |
| 2012-04-03 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
A - Award | 459 550 | 459 550 | |||||
| 2012-03-13 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
| 2012-03-02 |
|
4 | ABPI |
ACCENTIA BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 300 000 | 300 000 | |||||
| 2012-02-17 |
|
4 | ABPI |
ACCENTIA BIOPHARMACEUTICALS INC
Common Stock |
J - Other | −125 000 | 3 935 992 | −3,08 | ||||
| 2012-02-17 |
|
4 | ABPI |
ACCENTIA BIOPHARMACEUTICALS INC
Common Stock |
J - Other | −375 000 | 0 | −100,00 | ||||
| 2012-01-19 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock Purchase Warrant |
M - Exercise | −590 909 | 0 | −100,00 | ||||
| 2012-01-19 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock |
F - Taxes | −497 604 | 217 858 | −69,55 | 0,38 | −189 090 | 82 786 | |
| 2012-01-19 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock |
M - Exercise | 590 909 | 715 462 | 474,42 | 0,32 | 189 091 | 228 948 |
